Insufficient scRNA-seq data for expression of AJUBA at single-cell level.
Insufficient scRNA-seq data for expression of AJUBA at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 1693.38 | 653 / 653 | 97% | 28.90 | 584 / 605 |
uterus | 100% | 2219.55 | 170 / 170 | 96% | 37.78 | 442 / 459 |
ovary | 100% | 1637.08 | 180 / 180 | 94% | 22.48 | 404 / 430 |
lung | 97% | 1604.09 | 562 / 578 | 95% | 26.31 | 1103 / 1155 |
bladder | 100% | 842.67 | 21 / 21 | 90% | 19.96 | 454 / 504 |
esophagus | 94% | 1456.36 | 1355 / 1445 | 96% | 31.02 | 176 / 183 |
liver | 96% | 2094.19 | 216 / 226 | 94% | 25.95 | 383 / 406 |
kidney | 99% | 1835.18 | 88 / 89 | 90% | 25.88 | 814 / 901 |
breast | 96% | 1103.11 | 441 / 459 | 88% | 14.90 | 987 / 1118 |
pancreas | 88% | 625.60 | 288 / 328 | 88% | 13.17 | 156 / 178 |
prostate | 99% | 1624.18 | 243 / 245 | 69% | 7.47 | 347 / 502 |
stomach | 73% | 515.07 | 263 / 359 | 90% | 14.44 | 257 / 286 |
intestine | 61% | 346.52 | 592 / 966 | 91% | 14.49 | 480 / 527 |
skin | 100% | 4350.90 | 1809 / 1809 | 51% | 5.74 | 240 / 472 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.13 | 1 / 1 |
blood vessel | 99% | 1353.34 | 1319 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 39.47 | 44 / 45 |
adrenal gland | 78% | 463.23 | 201 / 258 | 17% | 1.66 | 38 / 230 |
adipose | 90% | 809.68 | 1087 / 1204 | 0% | 0 | 0 / 0 |
heart | 82% | 553.62 | 702 / 861 | 0% | 0 | 0 / 0 |
spleen | 66% | 375.87 | 159 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 50% | 3.88 | 40 / 80 |
brain | 3% | 18.21 | 89 / 2642 | 37% | 3.40 | 258 / 705 |
peripheral blood | 5% | 26.29 | 46 / 929 | 0% | 0 | 0 / 0 |
muscle | 3% | 16.80 | 26 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046474 | Biological process | glycerophospholipid biosynthetic process |
GO_0035278 | Biological process | miRNA-mediated gene silencing by inhibition of translation |
GO_0030032 | Biological process | lamellipodium assembly |
GO_0031328 | Biological process | positive regulation of cellular biosynthetic process |
GO_0007010 | Biological process | cytoskeleton organization |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0031334 | Biological process | positive regulation of protein-containing complex assembly |
GO_0035331 | Biological process | negative regulation of hippo signaling |
GO_0035195 | Biological process | miRNA-mediated post-transcriptional gene silencing |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0030334 | Biological process | regulation of cell migration |
GO_0001666 | Biological process | response to hypoxia |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0016339 | Biological process | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO_0048041 | Biological process | focal adhesion assembly |
GO_0008104 | Biological process | protein localization |
GO_0035313 | Biological process | wound healing, spreading of epidermal cells |
GO_1900037 | Biological process | regulation of cellular response to hypoxia |
GO_0005886 | Cellular component | plasma membrane |
GO_0005813 | Cellular component | centrosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005925 | Cellular component | focal adhesion |
GO_0000932 | Cellular component | P-body |
GO_0005911 | Cellular component | cell-cell junction |
GO_0005829 | Cellular component | cytosol |
GO_0005912 | Cellular component | adherens junction |
GO_0030027 | Cellular component | lamellipodium |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0045294 | Molecular function | alpha-catenin binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0051015 | Molecular function | actin filament binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0030295 | Molecular function | protein kinase activator activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | AJUBA |
Protein name | LIM domain-containing protein ajuba Ajuba LIM protein |
Synonyms | JUB |
Description | FUNCTION: Adapter or scaffold protein which participates in the assembly of numerous protein complexes and is involved in several cellular processes such as cell fate determination, cytoskeletal organization, repression of gene transcription, mitosis, cell-cell adhesion, cell differentiation, proliferation and migration. Contributes to the linking and/or strengthening of epithelia cell-cell junctions in part by linking adhesive receptors to the actin cytoskeleton. May be involved in signal transduction from cell adhesion sites to the nucleus. Plays an important role in regulation of the kinase activity of AURKA for mitotic commitment. Also a component of the IL-1 signaling pathway modulating IL-1-induced NFKB1 activation by influencing the assembly and activity of the PRKCZ-SQSTM1-TRAF6 multiprotein signaling complex. Functions as an HDAC-dependent corepressor for a subset of GFI1 target genes. Acts as a transcriptional corepressor for SNAI1 and SNAI2/SLUG-dependent repression of E-cadherin transcription. Acts as a hypoxic regulator by bridging an association between the prolyl hydroxylases and VHL enabling efficient degradation of HIF1A. Positively regulates microRNA (miRNA)-mediated gene silencing. Negatively regulates the Hippo signaling pathway and antagonizes phosphorylation of YAP1. . |
Accessions | ENST00000553592.5 Q96IF1 ENST00000262713.7 [Q96IF1-1] ENST00000397388.7 [Q96IF1-2] ENST00000556731.5 ENST00000553736.1 ENST00000553911.1 G3V481 H0YJL9 G3V5F5 |